PUBLICATIONS · 21115869
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2011 Jan 10
- First author
- Bagatell R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bagatell R
- type
- Author
- name
- London WB
- type
- Author
- name
- Wagner LM
- type
- Author
- name
- Voss SD
- type
- Author
- name
- Stewart CF
- type
- Author
- name
- Maris JM
- type
- Author
- name
- Kretschmar C
- type
- Author
- name
- Cohn SL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bagatell R
- type
- Author
- name
- London WB
- type
- Author
- name
- Wagner LM
- type
- Author
- name
- Voss SD
- type
- Author
- name
- Stewart CF
- type
- Author
- name
- Maris JM
- type
- Author
- name
- Kretschmar C
- type
- Author
- name
- Cohn SL
- type
- Author
- bibliography ids
- nci-bib-d60fbc9804bc0bacd094be62
- book metadata
- content sha256
- 7224660eafa1b4210f9f88545c1f8fe079e4cc8a79c90d9192ec551e9c89ffe1
- document type
- citation
- dois
- 10.1200/JCO.2010.31.7107
- electronic publication date
- display
- 2010 Nov 29
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21115869
- immutable id
- pubmed:21115869@7224660eafa1b4210f9f88545c1f8fe079e4cc8a79c90d9192ec551e9c89ffe1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 2
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 208-13
- volume
- 29
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21115869
- provenance
- batch id
- edef4b7f1a2a505cd5a9
- provider
- NCBI PubMed ESummary
- record sha256
- 6b0f253e3fc88601dbf271c058f6a7c903e6682aff32112a82941ea97a31955a
- response sha256
- d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
- retrieved at
- 2026-09-09T23:46:38.027615+00:00
- publication date
- display
- 2011 Jan 10
- precision
- day
- year
- 2011
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.
Preserved source evidence · Not medical advice
Triangle